Literature DB >> 12576796

The natural history of the overactive bladder and detrusor overactivity. A review of the evidence regarding the long-term outcome of the overactive bladder.

Stephen Garnett1, Paul Abrams.   

Abstract

PURPOSE: The overactive bladder is a widespread medical condition with significant impact on quality of life. We review the existing evidence about the prevalence, impact and long-term followup of the overactive bladder. We also summarize the new International Continence Society terminology associated with the overactive bladder.
MATERIALS AND METHODS: A MEDLINE search of all available literature regarding the epidemiology and long-term followup or outcome of the overactive bladder was performed. All articles and relevant resources cited in those articles were reviewed.
RESULTS: The new International Continence Society terminology and definitions will allow greater consistency in future research. Two large, recently published surveys of the prevalence of overactive bladder give new insight into the widespread nature of the problem and its significant impact on quality of life. There is little good quality evidence currently available on the long-term outcome of overactive bladder.
CONCLUSIONS: There is little published evidence regarding the natural history of overactive bladder. While recent studies have improved understanding the prevalence of the condition, we still know little about long-term outcome. The few published studies suggest that it is a chronic condition that persists urodynamically and symptomatically.

Entities:  

Mesh:

Year:  2003        PMID: 12576796     DOI: 10.1097/01.ju.0000050305.05345.40

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  [Urgent urinary incontinence due to taking troxerutine sachets].

Authors:  Dolores Aroca García; Pahola Gómez Rivas
Journal:  Aten Primaria       Date:  2010-03-19       Impact factor: 1.137

2.  Extending the rationale of combination therapy to unresponsive erectile dysfunction.

Authors:  Christopher Reece; Rajeev Kumar; Diedre Nienow; Ajay Nehra
Journal:  Rev Urol       Date:  2007

3.  Complication rate of neurogenic lower urinary tract dysfunction after spinal cord injury in Taiwan.

Authors:  Edward Chia-Cheng Lai; Yea-Huei Kao Yang; Hann-Chorng Kuo
Journal:  Int Urol Nephrol       Date:  2013-12-18       Impact factor: 2.370

4.  CUA guideline on adult overactive bladder.

Authors:  Jacques Corcos; Mikolaj Przydacz; Lysanne Campeau; Gary Gray; Duane Hickling; Christiane Honeine; Sidney B Radomski; Lynn Stothers; Adrian Wagg; Frcp Lond
Journal:  Can Urol Assoc J       Date:  2017-05-09       Impact factor: 1.862

5.  Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.

Authors:  Dyfrig A Hughes; Dominique Dubois
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

6.  [Epidemiology and etiology of overactive bladder].

Authors:  C Hampel; R Gillitzer; S Pahernik; M Hohenfellner; J W Thüroff
Journal:  Urologe A       Date:  2003-04-29       Impact factor: 0.639

Review 7.  Benefit-risk assessment of tolterodine in the treatment of overactive bladder in adults.

Authors:  Alan D Garely; Lara Burrows
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

8.  Rehabilitation versus drug therapy for urge urinary incontinence: long-term outcomes.

Authors:  Rachel Kafri; Jeffrey Shames; Meir Raz; Michal Katz-Leurer
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-06-05

Review 9.  Mixed incontinence: stressing about urge.

Authors:  Jennifer Tash Anger; Larissa V Rodríguez
Journal:  Curr Urol Rep       Date:  2004-12       Impact factor: 3.092

Review 10.  Evaluation and management of refractory overactive bladder.

Authors:  Humphrey O Atiemo; Sandip P Vasavada
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.